<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>2829276</identifier>
<setSpec>0325-7541</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Riera, N E</dc:author>
<dc:author>Scaglione, C</dc:author>
<dc:author>De la Barrera, S</dc:author>
<dc:author>Pérez Blanco, R</dc:author>
<dc:author>Fejes, M</dc:author>
<dc:author>de Bracco, M M</dc:author>
<dc:description xml:lang="en">Serologic reactivity against EBV-infected lines was assayed in patients with AIDS (n = 4) or the AIDS related complex (AIDS-RC) (n = 46) residing in Argentina. Anti-VCA serology was comparable to that of controls. However sera from AIDS and AIDS-RC could induce antibody dependent cell mediated cytotoxicity (ADCC) to EBV-infected cell lines (P3HRIK and Raji). ADCC activity could be recovered in the high molecular weight fractions of AIDS and AIDS-RC sera. ADCC was observed in sera with high levels of PEG precipitable material (PEG-pp) but was unrelated to the presence of complement-fixing immune complexes (Clq-F) or to anti-VCA titers. Fc receptor (FcR) bridging between target cells FcR and effector cells FcR may play a role in the outcome of total ADCC.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>1985 </dc:date>
<dc:title xml:lang="es">Citotoxicidad inducida por el suero de pacientes con SIDA y alto riesgo de SIDA (SAR) contra células infectadas por el virus de Epstein-Barr.</dc:title>
<dc:title xml:lang="en">[Cytotoxicity induced by the serum of patients with AIDS and at high risk of AIDS against cells infected with Epstein-Barr virus].</dc:title>
<dc:publisher>Revista Argentina de microbiologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
